文献速递系统性红斑狼疮其他结缔组织病

全谱系ANA阳性自身免疫的外周血RNA测序揭示起始免疫病理机制

Blood RNA-sequencing across the continuum of ANA-positive autoimmunity reveals insights into initiating immunopathology.
PubMed 文献 · Ann Rheum Dis · 2024-09-30

研究对35例非诊断性症状的ANA阳性受试者基线外周血单个核细胞行bulk RNA测序,其中12个月进展为可分类SLE者15例、稳定亚临床ANA阳性者20例,并与15名健康者和18例SLE患者比较。ANA阳性者转录组广泛失调且更接近SLE,进展者干扰素模块评分升高、线粒体氧化磷酸化复合体I组分基线下调与进展相关。

要点

  • ANA阳性者无论是否进展为SLE,转录组均广泛失调且更接近SLE而非健康免疫状态。
  • ANA阳性进展者干扰素模块评分升高,其组成基因可被I型和II型干扰素诱导。
  • 线粒体氧化磷酸化复合体I组分基线下调与进展为SLE显著相关,但不直接与干扰素模块活性相关。

核心结论

  • ANA阳性无论临床轨迹如何均存在深度失调,转录组上更接近SLE而非健康免疫状态。
  • 代谢紊乱与I型干扰素活化在ANA阳性临床前阶段早期出现,并与区分后续临床演变的转录组谱相关。

研究设计与样本

  • 对35例有非诊断性症状的ANA阳性受试者基线外周血单个核细胞行bulk RNA测序,采用差异基因表达、加权基因共表达网络分析、细胞亚群解卷积和功能富集分析。
  • ANA阳性受试者中12个月进展为可分类SLE者15例、稳定亚临床ANA阳性者20例,与15名健康受试者和18例SLE患者比较。

主要发现

  • 与健康对照相比,ANA阳性者转录组广泛失调,CD4+初始T细胞和静息NK细胞减少,而活化树突状细胞增多。
  • B细胞淋巴细胞减少见于SLE患者但不见于ANA阳性受试者。
  • 三分之二的失调基因在ANA阳性进展者与未进展者中共同存在。
  • ANA阳性进展者干扰素模块评分升高,其组成基因在体外可被I型干扰素和II型干扰素诱导。
  • 线粒体氧化磷酸化复合体I组分基线下调与进展为SLE显著相关,但不直接与干扰素模块活性相关;未进展者细胞因子谱更多样。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Mechanisms underpinning clinical evolution to systemic lupus erythematosus (SLE) from preceding antinuclear antibodies (ANA) positivity are poorly understood. This study aimed to understand blood immune cell transcriptional signatures associated with subclinical ANA positivity, and progression or non-progression to SLE. METHODS: Bulk RNA-sequencing of peripheral blood mononuclear cells isolated at baseline from 35 ANA positive (ANA+) subjects with non-diagnostic symptoms was analysed using differential gene expression, weighted gene co-expression network analysis, deconvolution of cell subsets and functional enrichment analyses. ANA+ subjects, including those progressing to classifiable SLE at 12 months (n=15) and those with stable subclinical ANA positivity (n=20), were compared with 15 healthy subjects and 18 patients with SLE. RESULTS: ANA+ subjects demonstrated extensive transcriptomic dysregulation compared with healthy controls with reduced CD4+naïve T-cells and resting NK cells, but higher activated dendritic cells. B-cell lymphopenia was evident in SLE but not ANA+ subjects. Two-thirds of dysregulated genes were common to ANA+ progressors and non-progressors. ANA+ progressors showed elevated modular interferon signature in which constituent genes were inducible by both type I interferon (IFN-I) and type II interferon (IFN-II) in vitro. Baseline downregulation of mitochondrial oxidative phosphorylation complex I components significantly associated with progression to SLE but did not directly correlate with IFN modular activity. Non-progressors demonstrated more diverse cytokine profiles. CONCLUSIONS: ANA positivity, irrespective of clinical trajectory, is profoundly dysregulated and transcriptomically closer to SLE than to healthy immune function. Metabolic derangements and IFN-I activation occur early in the ANA+ preclinical phase and associated with diverging transcriptomic profiles which distinguish subsequent clinical evolution.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Carter LM, Md Yusof MY, Wigston Z, et al. Blood RNA-sequencing across the continuum of ANA-positive autoimmunity reveals insights into initiating immunopathology. Ann Rheum Dis. 2024. PMID: 38740438. doi:10.1136/ard-2023-225349

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。